Stockreport

IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced ovarian cancer Company to hold conference call today at 11:00 a.m. ET [Read more]